nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—peripheral nervous system neoplasm	0.433	1	CbGaD
Etravirine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0503	0.136	CbGbCtD
Etravirine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0503	0.136	CbGbCtD
Etravirine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0482	0.13	CbGbCtD
Etravirine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0349	0.0943	CbGbCtD
Etravirine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0301	0.0815	CbGbCtD
Etravirine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.028	0.0758	CbGbCtD
Etravirine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0215	0.0581	CbGbCtD
Etravirine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0206	0.0558	CbGbCtD
Etravirine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.02	0.0542	CbGbCtD
Etravirine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0197	0.0532	CbGbCtD
Etravirine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0134	0.0363	CbGbCtD
Etravirine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0129	0.0348	CbGbCtD
Etravirine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0118	0.0319	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00804	0.0217	CbGbCtD
Etravirine—Rilpivirine—ABCB1—peripheral nervous system neoplasm	0.00198	1	CrCbGaD
Etravirine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000196	0.00101	CcSEcCtD
Etravirine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000195	0.001	CcSEcCtD
Etravirine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000195	0.000998	CcSEcCtD
Etravirine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000195	0.000998	CcSEcCtD
Etravirine—Rash—Topotecan—peripheral nervous system neoplasm	0.000195	0.000997	CcSEcCtD
Etravirine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000194	0.000996	CcSEcCtD
Etravirine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000194	0.000996	CcSEcCtD
Etravirine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000194	0.000994	CcSEcCtD
Etravirine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000194	0.000992	CcSEcCtD
Etravirine—Headache—Topotecan—peripheral nervous system neoplasm	0.000193	0.000991	CcSEcCtD
Etravirine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000193	0.000989	CcSEcCtD
Etravirine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000193	0.000989	CcSEcCtD
Etravirine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000193	0.000989	CcSEcCtD
Etravirine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000193	0.000988	CcSEcCtD
Etravirine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000193	0.000988	CcSEcCtD
Etravirine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000193	0.000988	CcSEcCtD
Etravirine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000192	0.000985	CcSEcCtD
Etravirine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000192	0.000985	CcSEcCtD
Etravirine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000192	0.000984	CcSEcCtD
Etravirine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000192	0.000983	CcSEcCtD
Etravirine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000192	0.000983	CcSEcCtD
Etravirine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000192	0.000982	CcSEcCtD
Etravirine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.00098	CcSEcCtD
Etravirine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000191	0.00098	CcSEcCtD
Etravirine—Pain—Vincristine—peripheral nervous system neoplasm	0.000191	0.00098	CcSEcCtD
Etravirine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000191	0.00098	CcSEcCtD
Etravirine—Rash—Melphalan—peripheral nervous system neoplasm	0.000191	0.000977	CcSEcCtD
Etravirine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00019	0.000976	CcSEcCtD
Etravirine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.000972	CcSEcCtD
Etravirine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00097	CcSEcCtD
Etravirine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000966	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000188	0.000962	CcSEcCtD
Etravirine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000187	0.000957	CcSEcCtD
Etravirine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000957	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000953	CcSEcCtD
Etravirine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.000945	CcSEcCtD
Etravirine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.00094	CcSEcCtD
Etravirine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.00094	CcSEcCtD
Etravirine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000183	0.00094	CcSEcCtD
Etravirine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000183	0.000937	CcSEcCtD
Etravirine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000937	CcSEcCtD
Etravirine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000183	0.000936	CcSEcCtD
Etravirine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000182	0.000932	CcSEcCtD
Etravirine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000182	0.000932	CcSEcCtD
Etravirine—Infection—Etoposide—peripheral nervous system neoplasm	0.00018	0.000922	CcSEcCtD
Etravirine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000921	CcSEcCtD
Etravirine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00018	0.00092	CcSEcCtD
Etravirine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00018	0.00092	CcSEcCtD
Etravirine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000178	0.00091	CcSEcCtD
Etravirine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000177	0.000909	CcSEcCtD
Etravirine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000906	CcSEcCtD
Etravirine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000177	0.000906	CcSEcCtD
Etravirine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000177	0.000906	CcSEcCtD
Etravirine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000176	0.000902	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000898	CcSEcCtD
Etravirine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000175	0.000897	CcSEcCtD
Etravirine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000897	CcSEcCtD
Etravirine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000891	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000885	CcSEcCtD
Etravirine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000173	0.000885	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000882	CcSEcCtD
Etravirine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000172	0.000881	CcSEcCtD
Etravirine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.000878	CcSEcCtD
Etravirine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000876	CcSEcCtD
Etravirine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000875	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000867	CcSEcCtD
Etravirine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000867	CcSEcCtD
Etravirine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000853	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000852	CcSEcCtD
Etravirine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000165	0.000844	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000838	CcSEcCtD
Etravirine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000163	0.000835	CcSEcCtD
Etravirine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000163	0.000834	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00083	CcSEcCtD
Etravirine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000825	CcSEcCtD
Etravirine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000161	0.000825	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000825	CcSEcCtD
Etravirine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00016	0.000822	CcSEcCtD
Etravirine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000159	0.000816	CcSEcCtD
Etravirine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000814	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000809	CcSEcCtD
Etravirine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.000809	CcSEcCtD
Etravirine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000157	0.000807	CcSEcCtD
Etravirine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000802	CcSEcCtD
Etravirine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000156	0.000801	CcSEcCtD
Etravirine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000156	0.000801	CcSEcCtD
Etravirine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000156	0.0008	CcSEcCtD
Etravirine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000156	0.0008	CcSEcCtD
Etravirine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000795	CcSEcCtD
Etravirine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000155	0.000794	CcSEcCtD
Etravirine—Pain—Etoposide—peripheral nervous system neoplasm	0.000155	0.000794	CcSEcCtD
Etravirine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000793	CcSEcCtD
Etravirine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000786	CcSEcCtD
Etravirine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000153	0.000784	CcSEcCtD
Etravirine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000772	CcSEcCtD
Etravirine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000149	0.000765	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000764	CcSEcCtD
Etravirine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000149	0.000762	CcSEcCtD
Etravirine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000148	0.000759	CcSEcCtD
Etravirine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000148	0.000758	CcSEcCtD
Etravirine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000756	CcSEcCtD
Etravirine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.00075	CcSEcCtD
Etravirine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000749	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000748	CcSEcCtD
Etravirine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000747	CcSEcCtD
Etravirine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000745	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000742	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00074	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000736	CcSEcCtD
Etravirine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000143	0.000734	CcSEcCtD
Etravirine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000143	0.000734	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000734	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000732	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000729	CcSEcCtD
Etravirine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000142	0.000729	CcSEcCtD
Etravirine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000727	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000723	CcSEcCtD
Etravirine—Rash—Vincristine—peripheral nervous system neoplasm	0.000141	0.000723	CcSEcCtD
Etravirine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000141	0.000722	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00072	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000718	CcSEcCtD
Etravirine—Headache—Vincristine—peripheral nervous system neoplasm	0.00014	0.000718	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000714	CcSEcCtD
Etravirine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000706	CcSEcCtD
Etravirine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000693	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000693	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000684	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000133	0.000684	CcSEcCtD
Etravirine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000133	0.000681	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00068	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000678	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000674	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000669	CcSEcCtD
Etravirine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00013	0.000666	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000666	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000665	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000664	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000662	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00066	CcSEcCtD
Etravirine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000644	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000642	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000641	CcSEcCtD
Etravirine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000639	CcSEcCtD
Etravirine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000638	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000638	CcSEcCtD
Etravirine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000124	0.000635	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000633	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000629	CcSEcCtD
Etravirine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000628	CcSEcCtD
Etravirine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000626	CcSEcCtD
Etravirine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000619	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000615	CcSEcCtD
Etravirine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00012	0.000614	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000612	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000611	CcSEcCtD
Etravirine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000602	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000601	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000594	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000592	CcSEcCtD
Etravirine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Etravirine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000589	CcSEcCtD
Etravirine—Rash—Etoposide—peripheral nervous system neoplasm	0.000114	0.000585	CcSEcCtD
Etravirine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000114	0.000585	CcSEcCtD
Etravirine—Headache—Etoposide—peripheral nervous system neoplasm	0.000113	0.000582	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000581	CcSEcCtD
Etravirine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000579	CcSEcCtD
Etravirine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000575	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000573	CcSEcCtD
Etravirine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000573	CcSEcCtD
Etravirine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000572	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00056	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000556	CcSEcCtD
Etravirine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000552	CcSEcCtD
Etravirine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000108	0.000551	CcSEcCtD
Etravirine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00055	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000547	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000545	CcSEcCtD
Etravirine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000541	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000539	CcSEcCtD
Etravirine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000536	CcSEcCtD
Etravirine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000532	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000531	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00053	CcSEcCtD
Etravirine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000529	CcSEcCtD
Etravirine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000525	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000519	CcSEcCtD
Etravirine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000517	CcSEcCtD
Etravirine—Shock—Epirubicin—peripheral nervous system neoplasm	9.99e-05	0.000512	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000511	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.00051	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000509	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000509	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000505	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.82e-05	0.000503	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000501	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000499	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000496	CcSEcCtD
Etravirine—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000496	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000491	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.000485	CcSEcCtD
Etravirine—Infection—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000478	CcSEcCtD
Etravirine—Shock—Doxorubicin—peripheral nervous system neoplasm	9.24e-05	0.000474	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.000472	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.000471	CcSEcCtD
Etravirine—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000471	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000468	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.12e-05	0.000467	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.000465	CcSEcCtD
Etravirine—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000463	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000459	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.83e-05	0.000452	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.77e-05	0.000449	CcSEcCtD
Etravirine—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000449	CcSEcCtD
Etravirine—Constipation—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000445	CcSEcCtD
Etravirine—Pain—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000445	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000435	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.44e-05	0.000432	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000429	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000428	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000426	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.17e-05	0.000419	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.11e-05	0.000416	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000415	CcSEcCtD
Etravirine—Pain—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000412	CcSEcCtD
Etravirine—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000412	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000411	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000411	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000397	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000394	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000383	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000381	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000381	CcSEcCtD
Etravirine—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.29e-05	0.000373	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000356	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000355	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000345	CcSEcCtD
Etravirine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000344	CcSEcCtD
Etravirine—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000331	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000329	CcSEcCtD
Etravirine—Rash—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000328	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000328	CcSEcCtD
Etravirine—Headache—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000326	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000318	CcSEcCtD
Etravirine—Nausea—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000309	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000306	CcSEcCtD
Etravirine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000304	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000303	CcSEcCtD
Etravirine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000302	CcSEcCtD
Etravirine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000286	CcSEcCtD
